AirSculpt Technologies, a provider of minimally invasive body contouring procedures, has announced its first national partnership with Tiger Aesthetics to offer alloClae — an off-the-shelf structural adipose tissue allograft designed for aesthetic body enhancements — across select locations beginning in August, with plans for nationwide availability by the end of 2026.
This collaboration expands AirSculpt's existing portfolio of fat removal and transfer techniques by introducing a ready-to-use tissue product that can be injected to add natural-looking volume and refine contours in areas such as the hips, buttocks, and breasts, as well as to correct irregularities following liposuction. The product is typically administered in-office in under an hour and delivers immediate visual results with minimal recovery time.
Image Credit: AirSculpt Technologies
What Makes This Trend Stand Out
- Injectable Tissue Augmentation
- Ready-to-use adipose allografts are reshaping body enhancement by offering natural-looking volume without traditional fat harvesting procedures.
- Minimally Invasive Contouring
- In-office aesthetic procedures with shorter recovery times are expanding consumer access to personalized body shaping solutions.
- Off-the-shelf Biologic Fillers
- Standardized biologic materials are creating new possibilities for scalable, procedure-efficient enhancement across multiple treatment areas.
Sectors Adopting This
- Aesthetic Medicine
- Clinics are broadening treatment portfolios with injectable structural tissues that complement existing body contouring and fat transfer services.
- Biotechnology
- Tissue-engineered and donor-derived products are strengthening the connection between regenerative science and cosmetic procedure innovation.
- Medical Devices
- Procedure platforms and delivery systems for injectable allografts are becoming important enablers of faster, office-based aesthetic treatments.
